Trends in frailty in brain tumor care during the COVID-19 pandemic in a nationwide hospital network in Germany
Description
CONCLUSION: Even though our findings are limited in that the HFRS is validated only for patients ≥ 75 years of age, our study among patients of all ages hospitalized for brain tumors in Germany suggests a marked decrease in levels of frailty and in
